Murine coronavirus cell type dependent interaction with the type I interferon response

Viruses

Volumn 1, Issue 3, 2009, Pages 689-712

  Rose, Kristine M ^a   Weiss, Susan R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

CNS infection; IFN signaling; Murine coronavirus; Virus induced IFN induction

Indexed keywords

EID: 77951994186     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v1030689     Document Type: Review

References (94)

1. Weiss, S.R.; Navas-Martin, S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol. Mol. Biol. Rev. 2005, 69, 635-664.
2. Woo, P.C.; Lau, S.K.; Huang, Y.; Tsoi, H.W.; Chan, K.H.; Yuen, K.Y. Phylogenetic and recombination analysis of coronavirus HKU1, a novel coronavirus from patients with pneumonia. Arch. Virol. 2005, 150, 2299-2311.
3. Peiris, J.S.; Lai, S.T.; Poon, L.L.; Guan, Y.; Yam, L.Y.; Lim, W.; Nicholls, J.; Yee, W.K.; Yan, W.W.; Cheung, M.T.; Cheng, V.C.; Chan, K.H.; Tsang, D.N.; Yung, R.W.; Ng, T.K.; Yuen, K.Y. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003, 361, 1319-1325.
4. Peiris, J.S.; Chu, C.M.; Cheng, V.C.; Chan, K.S.; Hung, I.F.; Poon, L.L.; Law, K.I.; Tang, B.S.; Hon, T.Y.; Chan, C.S.; Chan, K.H.; Ng, J.S.; Zheng, B.J.; Ng, W.L.; Lai, R.W.; Guan, Y.; Yuen, K.Y. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 2003, 361, 1767-1772.
5. Zhong, N.S.; Zheng, B.J.; Li, Y.M.; Poon; Xie, Z.H.; Chan, K.H.; Li, P.H.; Tan, S.Y.; Chang, Q.; Xie, J.P.; Liu, X.Q.; Xu, J.; Li, D.X.; Yuen, K.Y.; Peiris; Guan, Y. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet 2003, 362, 1353-1358.
6. Guan, Y.; Zheng, B.J.; He, Y. Q.; Liu, X.L.; Zhuang, Z.X.; Cheung, C.L.; Luo, S.W.; Li, P.H.; Zhang, L.J.; Guan, Y.J.; Butt, K.M.; Wong, K.L.; Chan, K.W.; Lim, W.; Shortridge, K.F.; Yuen, K.Y.; Peiris, J.S.; Poon, L.L. Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China. Science 2003, 302, 276-278.
7. Song, H.D.; Tu, C.C.; Zhang, G.W.; Wang, S.Y.; Zheng, K.; Lei, L.C.; Chen, Q.X.; Gao, Y.W.; Zhou, H.Q.; Xiang, H.; Zheng, H.J.; Chern, S.W.; Cheng, F.; Pan, C.M.; Xuan, H.; Chen, S.J.; Luo, H.M.; Zhou, D.H.; Liu, Y.F.; He, J.F.; Qin, P.Z.; Li, L.H.; Ren, Y.Q.; Liang, W.J.; Yu, Y.D.; Anderson, L.; Wang, M.; Xu, R.H.; Wu, X.W.; Zheng, H.Y.; Chen, J.D.; Liang, G.; Gao, Y.; Liao, M.; Fang, L.; Jiang, L.Y.; Li, H.; Chen, F.; Di, B.; He, L.J.; Lin, J.Y.; Tong, S.; Kong, X.; Du, L.; Hao, P.; Tang, H.; Bernini, A.; Yu, X.J.; Spiga, O.; Guo, Z.M.; Pan, H.Y.; He, W.Z.; Manuguerra, J.C.; Fontanet, A.; Danchin, A.; Niccolai, N.; Li, Y.X.; Wu, C.I.; Zhao, G.P. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc. Natl. Acad. Sci. U S A 2005, 102, 2430-2435.
8. Tu, C.; Crameri, G.; Kong, X.; Chen, J.; Sun, Y.; Yu, M.; Xiang, H.; Xia, X.; Liu, S.; Ren, T.; Yu, Y.; Eaton, B.T.; Xuan, H.; Wang, L.F. Antibodies to SARS coronavirus in civets. Emerg. Infect. Dis. 2004, 10, 2244-2248.
9. Lau, S.K.; Woo, P.C.; Li, K.S.; Huang, Y.; Tsoi, H.W.; Wong, B.H.; Wong, S.S.; Leung, S.Y.; Chan, K.H.; Yuen, K.Y. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc. Natl. Acad. Sci. U S A 2005, 102, 14040-14045.
10. Li, W.; Shi, Z.; Yu, M.; Ren, W.; Smith, C.; Epstein, J.H.; Wang, H.; Crameri, G.; Hu, Z.; Zhang, H.; Zhang, J.; McEachern, J.; Field, H.; Daszak, P.; Eaton, B.T.; Zhang, S.; Wang, L.F. Bats are natural reservoirs of SARS-like coronaviruses. Science 2005, 310, 676-679.
11. van der Hoek, L.; Pyrc, K.; Jebbink, M.F.; Vermeulen-Oost, W.; Berkhout, R.J.; Wolthers, K.C.; Wertheim-van Dillen, P.M.; Kaandorp, J.; Spaargaren, J.; Berkhout, B. Identification of a new human coronavirus. Nat. Med. 2004, 10, 368-373.
12. van der Hoek, L.; Sure, K.; Ihorst, G.; Stang, A.; Pyrc, K.; Jebbink, M.F.; Petersen, G.; Forster, J.; Berkhout, B.; Uberla, K. Croup is associated with the novel coronavirus NL63. PLoS Med. 2005, 2, e240.
13. Esper, F.; Weibel, C.; Ferguson, D.; Landry, M.L.; Kahn, J.S. Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children. J. Infect. Dis. 2005, 191, 492-498.
14. Homberger, F.R.; Zhang, L.; Barthold, S.W. Prevalence of enterotropic and polytropic mouse hepatitis virus in enzootically infected mouse colonies. Lab. Anim. Sci. 1998, 48, 50-54.
15. De Albuquerque, N.; Baig, E.; Ma, X.; Zhang, J.; He, W.; Rowe, A.; Habal, M.; Liu, M.; Shalev, I.; Downey, G.P.; Gorczynski, R.; Butany, J.; Leibowitz, J.; Weiss, S.R.; McGilvray, I.D.; Phillips, M.J.; Fish, E.N.; Levy, G.A. Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice. J. Virol. 2006, 80, 10382-10394.
16. Spaan, W.; Cavanagh, D.; Horzinek, M.C. Coronaviruses: structure and genome expression. J. Gen. Virol. 1988, 69 (Pt 12), 2939-2952.
17. Fischer, F.; Peng, D.; Hingley, S.T.; Weiss, S.R.; Masters, P.S. The internal open reading frame within the nucleocapsid gene of mouse hepatitis virus encodes a structural protein that is not essential for viral replication. J. Virol. 1997, 71, 996-1003.
18. Luytjes, W.; Bredenbeek, P.J.; Noten, A.F.; Horzinek, M.C.; Spaan, W.J. Sequence of mouse hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus. Virology 1988, 166, 415-422.
19. Kazi, L.; Lissenberg, A.; Watson, R.; de Groot, R.J.; Weiss, S.R. Expression of hemagglutinin esterase protein from recombinant mouse hepatitis virus enhances neurovirulence. J. Virol. 2005, 79, 15064-15073.
20. Marten, N.W.; Stohlman, S.A.; Bergmann, C.C. MHV infection of the CNS: mechanisms of immune-mediated control. Viral Immunol. 2001, 14, 1-18.
21. Perlman, S.; Dandekar, A.A. Immunopathogenesis of coronavirus infections: implications for SARS. Nat. Rev. Immunol. 2005, 5, 917-927.
22. Matthews, A.E.; Weiss, S.R.; Paterson, Y. Murine hepatitis virus--a model for virus-induced CNS demyelination. J. Neurovirol. 2002, 8, 76-85.
23. Matsuyama, S.; Henmi, S.; Ichihara, N.; Sone, S.; Kikuchi, T.; Ariga, T.; Taguchi, F. Protective effects of murine recombinant interferon-beta administered by intravenous, intramuscular or subcutaneous route on mouse hepatitis virus infection. Antiviral Res. 2000, 47, 131-137.
24. Garlinghouse, L.E., Jr.; Smith, A.L.; Holford, T. The biological relationship of mouse hepatitis virus (MHV) strains and interferon: in vitro induction and sensitivities. Arch. Virol. 1984, 82, 19-29.
25. Stohlman, S.A.; Sakaguchi, A.Y.; Hiti, A. Interferon production and activity in mouse neuroblastoma cells. Arch. Virol. 1978, 57, 91-96.
26. Wang, Q.; Haluskey, J.A.; Lavi, E. Coronavirus MHV-A59 causes upregulation of interferon-beta RNA in primary glial cell cultures. Adv. Exp. Med. Biol. 1998, 440, 451-454.
27. Racanelli, V.; Rehermann, B. The liver as an immunological organ. Hepatology 2006, 43, S54-62.
28. Narayanan, K.; Huang, C.; Makino, S. SARS coronavirus accessory proteins. Virus Res. 2008, 133, 113-121.
29. Frieman, M.; Baric, R. Mechanisms of severe acute respiratory syndrome pathogenesis and innate immunomodulation. Microbiol. Mol. Biol. Rev. 2008, 72, 672-685, Table of Contents.
30. Frieman, M.; Heise, M.; Baric, R. SARS coronavirus and innate immunity. Virus Res. 2008, 133, 101-112.
31. Thiel, V.; Weber, F. Interferon and cytokine responses to SARS-coronavirus infection. Cytokine Growth Factor Rev. 2008, 19, 121-132.
32. Paul, S.; Ricour, C.; Sommereyns, C.; Sorgeloos, F.; Michiels, T. Type I interferon response in the central nervous system. Biochimie 2007, 89, 770-778.
33. Versteeg, G.A.; Bredenbeek, P.J.; van den Worm, S.H.; Spaan, W.J. Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition. Virology 2007, 361, 18-26.
34. Weber, F.; Wagner, V.; Rasmussen, S.B.; Hartmann, R.; Paludan, S.R. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J. Virol. 2006, 80, 5059-5064.
35. Gallagher, T.M.; Buchmeier, M.J. Coronavirus spike proteins in viral entry and pathogenesis. Virology 2001, 279, 371-374.
36. Qiu, Z.; Hingley, S.T.; Simmons, G.; Yu, C.; Das Sarma, J.; Bates, P.; Weiss, S.R. Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spikemediated entry. J. Virol. 2006, 80, 5768-5776.
37. Jin, M.S.; Lee, J.O. Structures of the toll-like receptor family and its ligand complexes. Immunity 2008, 29, 182-191.
38. Saito, T.; Gale, M., Jr. Differential recognition of double-stranded RNA by RIG-I-like receptors in antiviral immunity. J. Exp. Med. 2008, 205, 1523-1527.
39. Kumar, H.; Kawai, T.; Akira, S. Pathogen recognition in the innate immune response. Biochem. J. 2009, 420, 1-16.
40. Platanias, L.C. Mechanisms of type-I-and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 2005, 5, 375-386.
41. Delhaye, S.; Paul, S.; Blakqori, G.; Minet, M.; Weber, F.; Staeheli, P.; Michiels, T. Neurons produce type I interferon during viral encephalitis. Proc. Natl. Acad. Sci. U S A 2006, 103, 7835-7840.
42. Zhou, H.; Perlman, S. Mouse hepatitis virus does not induce Beta interferon synthesis and does not inhibit its induction by double-stranded RNA. J. Virol. 2007, 81, 568-574.
43. Roth-Cross, J.K.; Martinez-Sobrido, L.; Scott, E.P.; Garcia-Sastre, A.; Weiss, S.R. Inhibition of the IFN-a/b Response by Mouse Hepatitis Virus (MHV) at Multiple Levels. J. Virol. 2007, 81, 7189-7199.
44. Ye, Y.; Hauns, K.; Langland, J.O.; Jacobs, B.L.; Hogue, B.G. Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist. J. Virol. 2007, 81, 2554-2563.
45. Ireland, D.D.; Stohlman, S.A.; Hinton, D.R.; Atkinson, R.; Bergmann, C.C. Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. J. Virol. 2008, 82, 300-310.
46. Cervantes-Barragan, L.; Zust, R.; Weber, F.; Spiegel, M.; Lang, K.S.; Akira, S.; Thiel, V.; Ludewig, B. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 2007, 109, 1131-1137.
47. Cervantes-Barragan, L.; Kalinke, U.; Zust, R.; Konig, M.; Reizis, B.; Lopez-Macias, C.; Thiel, V.; Ludewig, B. Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection. J. Immunol. 2009, 182, 1099-1106.
48. Roth-Cross, J.K.; Bender, S.J.; Weiss, S.R. Murine Coronavirus Mouse Hepatitis Virus (MHV) is Recognized by MDA5 and Induces Type I IFN in Brain Macrophages/Microglia. J. Virol. 2008.
49. Virelizier, J.L.; Gresser, I. Role of interferon in the pathogenesis of viral diseases of mice as demonstrated by the use of anti-interferon serum. V. Protective role in mouse hepatitis virus type 3 infection of susceptible and resistant strains of mice. J. Immunol. 1978, 120, 1616-1619.
50. Fuchizaki, U.; Kaneko, S.; Nakamoto, Y.; Sugiyama, Y.; Imagawa, K.; Kikuchi, M.; Kobayashi, K. Synergistic antiviral effect of a combination of mouse interferon-alpha and interferon-gamma on mouse hepatitis virus. J. Med. Virol. 2003, 69, 188-194.
51. Kato, Y.; Noda, Y.; Unoura, M.; Tanaka, N.; Kobayashi, K.; Hattori, N.; Hatano, K.; Kobayashi, S. Effect of exogenous mouse interferon on murine fulminant hepatitis induced by mouse hepatitis virus type 2. Dig. Dis. Sci. 1986, 31, 177-180.
52. Sone, S.; Izawa, A.; Narumi, H.; Kajita, A.; Tanabe, J.; Taguchi, F. The combination of type I interferon and ribavirin has an inhibitory effect on mouse hepatitis virus infection. Hepatol. Res. 2007, 37, 121-126.
53. Aurisicchio, L.; Delmastro, P.; Salucci, V.; Paz, O.G.; Rovere, P.; Ciliberto, G.; La Monica, N.; Palombo, F. Liver-specific alpha 2 interferon gene expression results in protection from induced hepatitis. J. Virol. 2000, 74, 4816-4823.
54. Chung, S.W.; Sinclair, S.B.; Fung, L.S.; Cole, E.H.; Levy, G.A. Effect of eicosanoids on induction of procoagulant activity by murine hepatitis virus strain 3 in vitro. Prostaglandins 1991, 42, 501-513.
55. Zust, R.; Cervantes-Barragan, L.; Kuri, T.; Blakqori, G.; Weber, F.; Ludewig, B.; Thiel, V. Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines. PLoS Pathog. 2007, 3, e109.
56. Zurney, J.; Howard, K.E.; Sherry, B. Basal expression levels of IFNAR and Jak-STAT components are determinants of cell-type-specific differences in cardiac antiviral responses. J. Virol. 2007, 81, 13668-13680.
57. Patterson, C.E.; Daley, J.K.; Rall, G.F. Neuronal survival strategies in the face of RNA viral infection. J. Infect. Dis. 2002, 186 Suppl 2, S215-219.
58. Macnamara, K.C.; Bender, S.J.; Chua, M.M.; Watson, R.; Weiss, S.R. Priming of CD8+ T cells during central nervous system infection with a murine coronavirus is strain-dependent. J. Virol. 2008, 6150-6160.
59. Rempel, J.D.; Murray, S.J.; Meisner, J.; Buchmeier, M.J. Differential regulation of innate and adaptive immune responses in viral encephalitis. Virology 2004, 318, 381-392.
60. Iacono, K.T.; Kazi, L.; Weiss, S.R. Both spike and background genes contribute to murine coronavirus neurovirulence J. Virol. 2006, 80, 6834-6843.
61. Glass, W.G.; Chen, B.P.; Liu, M.T.; Lane, T.E. Mouse hepatitis virus infection of the central nervous system: chemokine-mediated regulation of host defense and disease. Viral Immunol. 2002, 15, 261-272.
62. Detje, C.N.; Meyer, T.; Schmidt, H.; Kreuz, D.; Rose, J.K.; Bechmann, I.; Prinz, M.; Kalinke, U. Local type I IFN receptor signaling protects against virus spread within the central nervous system. J. Immunol. 2009, 182, 2297-2304.
63. Spiegel, M.; Pichlmair, A.; Martinez-Sobrido, L.; Cros, J.; Garcia-Sastre, A.; Haller, O.; Weber, F. Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J. Virol. 2005, 79, 2079-2086.
64. Wang, F.; Barrett, J.W.; Ma, Y.; Dekaban, G.A.; McFadden, G. Induction of alpha/beta interferon by myxoma virus is selectively abrogated when primary mouse embryo fibroblasts become immortalized. J. Virol. 2009, 83, 5928-5932.
65. Prentice, E.; Jerome, W.G.; Yoshimori, T.; Mizushima, N.; Denison, M.R. Coronavirus replication complex formation utilizes components of cellular autophagy. J. Biol. Chem. 2004, 279, 10136-10141.
66. Brockway, S.M.; Lu, X.T.; Peters, T.R.; Dermody, T.S.; Denison, M.R. Intracellular localization and protein interactions of the gene 1 protein p28 during mouse hepatitis virus replication. J. Virol. 2004, 78, 11551-11562.
67. Daffis, S.; Samuel, M.A.; Suthar, M.S.; Keller, B.C.; Gale, M., Jr.; Diamond, M.S. Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J. Virol. 2008, 82, 8465-8475.
68. Flanegan, J.B.; Petterson, R.F.; Ambros, V.; Hewlett, N.J.; Baltimore, D. Covalent linkage of a protein to a defined nucleotide sequence at the 5'-terminus of virion and replicative intermediate RNAs of poliovirus. Proc. Natl. Acad. Sci. U S A 1977, 74, 961-965.
69. Habjan, M.; Andersson, I.; Klingstrom, J.; Schumann, M.; Martin, A.; Zimmermann, P.; Wagner, V.; Pichlmair, A.; Schneider, U.; Muhlberger, E.; Mirazimi, A.; Weber, F. Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One 2008, 3, e2032.
70. Komuro, A.; Bamming, D.; Horvath, C.M. Negative regulation of cytoplasmic RNA-mediated antiviral signaling. Cytokine 2008, 43, 350-358.
71. Barral, P.M.; Sarkar, D.; Fisher, P.B.; Racaniello, V.R. RIG-I is cleaved during picornavirus infection. Virology 2009, 39, 171-6.
72. Rempel, J.D.; Murray, S.J.; Meisner, J.; Buchmeier, M.J. Mouse hepatitis virus neurovirulence: evidence of a linkage between S glycoprotein expression and immunopathology. Virology 2004, 318, 45-54.
73. Frieman, M.; Yount, B.; Heise, M.; Kopecky-Bromberg, S.A.; Palese, P.; Baric, R.S. Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J. Virol. 2007, 81, 9812-9824.
74. Kopecky-Bromberg, S.A.; Martinez-Sobrido, L.; Frieman, M.; Baric, R.A.; Palese, P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J. Virol. 2007, 81, 548-557.
75. Narayanan, K.; Huang, C.; Lokugamage, K.; Kamitani, W.; Ikegami, T.; Tseng, C.T.; Makino, S. Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells. J. Virol. 2008, 82, 4471-4479.
76. Wathelet, M.G.; Orr, M.; Frieman, M.B.; Baric, R.S. Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain. J. Virol. 2007, 81, 11620-11633.
77. Barretto, N.; Jukneliene, D.; Ratia, K.; Chen, Z.; Mesecar, A.D.; Baker, S.C. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J. Virol. 2005, 79, 15189-15198.
78. Devaraj, S.G.; Wang, N.; Chen, Z.; Chen, Z.; Tseng, M.; Barretto, N.; Lin, R.; Peters, C.J.; Tseng, C.T.; Baker, S.C.; Li, K. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. J. Biol. Chem. 2007, 282, 32208-32221.
79. Frieman, M.; Ratia, K.; Johnston, R.E.; Mesecar, A.D.; Baric, R.S. Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling. J. Virol. 2009, 83, 6689-6705.
80. Zheng, D.; Chen, G.; Guo, B.; Cheng, G.; Tang, H. PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production. Cell Res. 2008, 18, 1105-1113.
81. Changolkar, L.N.; Singh, G.; Pehrson, J.R. macroH2A1-dependent silencing of endogenous murine leukemia viruses. Mol. Cell Biol. 2008, 28, 2059-2065.
82. Gorbalenya, A.E.; Koonin, E.V.; Lai, M.M. Putative papain-related thiol proteases of positivestrand RNA viruses. Identification of rubi-and aphthovirus proteases and delineation of a novel conserved domain associated with proteases of rubi-, alpha-and coronaviruses. FEBS Lett. 1991, 288, 201-205.
83. Snijder, E.J.; Bredenbeek, P.J.; Dobbe, J.C.; Thiel, V.; Ziebuhr, J.; Poon, L.L.; Guan, Y.; Rozanov, M.; Spaan, W.J.; Gorbalenya, A.E. Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage. J. Mol. Biol. 2003, 331, 991-1004.
84. Putics, A.; Filipowicz, W.; Hall, J.; Gorbalenya, A.E.; Ziebuhr, J. ADP-ribose-1"-monophosphatase: a conserved coronavirus enzyme that is dispensable for viral replication in tissue culture. J. Virol. 2005, 79, 12721-12731.
85. Putics, A.; Gorbalenya, A.E.; Ziebuhr, J. Identification of protease and ADP-ribose 1"-monophosphatase activities associated with transmissible gastroenteritis virus non-structural protein 3. J. Gen. Virol. 2006, 87, 651-656.
86. Egloff, M.P.; Malet, H.; Putics, A.; Heinonen, M.; Dutartre, H.; Frangeul, A.; Gruez, A.; Campanacci, V.; Cambillau, C.; Ziebuhr, J.; Ahola, T.; Canard, B. Structural and Functional Basis for ADP-Ribose and Poly(ADP-Ribose) Binding by Viral Macro Domains. J. Virol. 2006, 80, 8493-8502.
87. Roth-Cross, J.K.; Stokes, H.; Chang, G.; Chua, M.M.; Thiel, V.; Weiss, S.R.; Gorbalenya, A.E.; Siddell, S.G. Organ-specific attenuation of murine hepatitis virus strain A59 by replacement of catalytic residues in the putative viral cyclic phosphodiesterase ns2. J. Virol. 2009, 83, 3743-3753.
88. Eriksson, K.K.; Cervantes-Barragan, L.; Ludewig, B.; Thiel, V. Mouse hepatitis virus liver pathology is dependent on ADP-ribose-1"-phosphatase, a viral function conserved in the alphalike supergroup. J. Virol. 2008, 82, 12325-12334.
89. Gold, M.G.; Smith, F.D.; Scott, J.D.; Barford, D. AKAP18 contains a phosphoesterase domain that binds AMP. J. Mol. Biol. 2008, 375, 1329-1343.
90. Piotrowski, Y.; Hansen, G.; Boomaars-van der Zanden, A.L.; Snijder, E.J.; Gorbalenya, A.E.; Hilgenfeld, R. Crystal structures of the X-domains of a Group-1 and a Group-3 coronavirus reveal that ADP-ribose-binding may not be a conserved property. Protein Sci. 2009, 18, 6-16.
91. Park, E.; Griffin, D.E. Interaction of Sindbis virus non-structural protein 3 with poly(ADP-ribose) polymerase 1 in neuronal cells. J. Gen. Virol. 2009, 90, 2073-2080.
92. Park, E.; Griffin, D.E. The nsP3 macro domain is important for Sindbis virus replication in neurons and neurovirulence in mice. Virology 2009, 388, 305-314.
93. Eckerle, L.D.; Lu, X.; Sperry, S.M.; Choi, L.; Denison, M.R. High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants. J. Virol. 2007, 81, 12135-12144.
94. Sperry, S.; Kazi, L.; Graham, R.; Baric, R.; Weiss, S.; Denison, M. Single amino acid substitutions in non-structural ORF1b-nsp14 and ORF2a 30kDa proteins of the murine coronavirus MHV-A59 are attenuating in mice. J. Virol. 2005, 79, 3391-3400.